-
Mashup Score: 0Trial Set to ADVANCE Knowledge in Sac Regression - 10 month(s) ago
An important head-to-head RCT of two2leading aortic stent-graft systems were discussed on Wednesday by Hence Verhagen, Chief of Vascular Surgery at Erasmus University Medical Center in Rotterdam, the Netherlands.
Source: HMP Global Learning NetworkCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0EnChEVAR: A Force for Standardization - 10 month(s) ago
Rather than a ‘bailout’ procedure for the chimney technique, EnChEVAR could become a standardized, therapeutic, complementary option.
Source: HMP Global Learning NetworkCategories: Cardiology News and Journals, Latest HeadlinesTweet-
EnChEVAR: A Force for Standardization Dr Konstantinos Donas discusses his talk from #LINC2023, which covered the evaluation and evolution of the chimney/snorkel endovascular technique in the treatment of complex aortic aneurysms. Read about it here: https://t.co/I8HJMiyhFA https://t.co/PMBD3dPdlG
-
-
Mashup Score: 0PROMISE-ing Updates for Percutaneous Deep Vein Arterialization - 10 month(s) ago
Transcatheter arterialization of the deep veins is safe and effective, and offers a potential new treatment option for patients facing amputation.
Source: HMP Global Learning NetworkCategories: Cardiology News and Journals, Latest HeadlinesTweet-
From #LINC2023: PROMISE-ing Updates for Percutaneous Deep Vein Arterialization Dr Miguel Montero-Baker provides six-month updates from a study in transcatheter arterialization of deep veins for the treatment of #CLTI in this presentation: https://t.co/R9rsEXEFFM https://t.co/LEsDe5td00
-
-
Mashup Score: 2PROSPECT MONSTER: Real-World Data Confirm Low-Dose DCB Efficacy in PAD - 10 month(s) ago
As in the COMPARE trial, the data show sustained treatment benefit to 1 year with low- and high-dose DCBs.
Source: TCTMD.comCategories: Cardiologists, Latest HeadlinesTweet-
Japan's PROSPECT MONSTER: no difference in primary patency at 12 months. @tatsuya_nakama @RamonVarcoeMD @EricSecemskyMD #LINC2023 https://t.co/9P3LJgQeZG
-
-
Mashup Score: 0VeinWay Traversa Venous Recanalization Device’s First Compassionate Use Cases Presented - Endovascular Today - 11 month(s) ago
June 7, 2023—VeinWay announced that the company’s Traversa venous recanalization device was used in a compassionate use case for venous re
Source: Endovascular TodayCategories: Cardiology News and Journals, Latest HeadlinesTweet-
VeinWay Traversa Venous Recanalization Device’s First Compassionate Use Cases Presented | #LINC2023 https://t.co/LAFlBoAq59
-
-
Mashup Score: 0What Works, What’s Noise? Novel Approaches Offer Hope in CLTI - 11 month(s) ago
Getting good data on wound healing and its impact on CLTI patients’ lives is an ongoing challenge, says Raghu Kolluri.
Source: TCTMD.comCategories: Cardiologists, Latest HeadlinesTweet-
“You're definitely seeing passion for these patients where people are throwing the kitchen sink at the disease process." #CLTI #woundcare #LINC2023 https://t.co/dwJD2zB1VA
-
-
Mashup Score: 0Good Real-World Outcomes Seen With Next-Generation Carotid Stent - 11 month(s) ago
Success for Europeans could be good news for US operators looking for CMS to ease CAS restrictions, says Peter Schneider.
Source: TCTMD.comCategories: Cardiologists, Latest HeadlinesTweet-
"What we saw is that we have a very low major adverse event rate in the real world in a patient setting with elective CAS." #carotidintervention #CAS #LINC2023 https://t.co/N4eHhunReP
-
-
Mashup Score: 0Biotronik’s Oscar Multifunctional Peripheral Catheter Begins Commercial Launch - Endovascular Today - 11 month(s) ago
June 5, 2023—Biotronik announced the limited release of its Oscar (“One Solution: Cross. Adjust. Restore”) multifunctional periphera
Source: Endovascular TodayCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Biotronik’s Oscar Multifunctional Peripheral Catheter Begins Commercial Launch | @BIOTRONIK_News #LINC2023 https://t.co/zhp7Fphuui
-
Trial Set to ADVANCE Knowledge in Sac Regression At #LINC2023, Drs Hence Verhagen and Marc Schermerhorn discussed the ADVANCE RCT, which compared the Endurant II/IIs Stent Graft System and Gore Excluder/Excluder Conformable AAA Endoprosthesis. Learn more: https://t.co/r1fpPAT4l9 https://t.co/rmdFgKjj9e